FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898294136> ?p ?o ?g. }

• W2898294136 endingPage "223" @default.
• W2898294136 startingPage "218" @default.
• W2898294136 abstract "Podoplanin (PDPN), a type I transmembrane sialoglycoprotein, is expressed in normal tissues, including lymphatic endothelial cells, pulmonary type I alveolar cells, and renal podocytes. The overexpression of PDPN in cancers is associated with hematogenous metastasis by interactions with the C-type lectin-like receptor 2 (CLEC-2). We have previously reported the development of a mouse monoclonal antibody (mAb) clone, PMab-38 (IgG1, kappa), against dog PDPN (dPDPN). PMab-38 reacted strongly with canine squamous cell carcinomas and melanomas, but not with lymphatic endothelial cells, indicating its cancer specificity. In this study, we developed and produced several mouse-canine chimeric antibodies originating from PMab-38. A mouse-canine chimeric antibody of subclass A (P38A) and a mouse-canine chimeric antibody of subclass B (P38B) were transiently produced using ExpiCHO-S cells. Core-fucose-deficient P38B (P38Bf) was developed using FUT8 knockout ExpiCHO-S cells. We compared the binding affinities, antibody-dependent cellular cytotoxicity (ADCC), and complement-dependent cytotoxicity (CDC) of P38A, P38B, and P38Bf against Chinese hamster ovary (CHO)/dPDPN cells. Flow cytometry analysis showed that the KD of P38A, P38B, and P38Bf were 1.9 × 10-7, 5.2 × 10-9, and 6.5 × 10-9, respectively. Both P38B and P38Bf revealed high ADCC activities against CHO/dPDPN cells; P38Bf demonstrated significantly higher ADCC compared with P38B, especially at low concentrations. P38B and P38Bf exhibited higher CDC activities against CHO/dPDPN cells. Conversely, P38A did not exhibit any ADCC or CDC activity. In summary, P38Bf is a good candidate for antibody therapy against dPDPN-expressing canine cancers." @default.
• W2898294136 created "2018-11-02" @default.
• W2898294136 creator A5000775867 @default.
• W2898294136 creator A5016361449 @default.
• W2898294136 creator A5016375050 @default.
• W2898294136 creator A5025832428 @default.
• W2898294136 creator A5032655219 @default.
• W2898294136 creator A5050043235 @default.
• W2898294136 creator A5060363731 @default.
• W2898294136 creator A5077624041 @default.
• W2898294136 date "2018-11-01" @default.
• W2898294136 modified "2023-10-17" @default.
• W2898294136 title "Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin" @default.
• W2898294136 cites W1636539495 @default.
• W2898294136 cites W1963537189 @default.
• W2898294136 cites W1973103227 @default.
• W2898294136 cites W1974376872 @default.
• W2898294136 cites W1988382766 @default.
• W2898294136 cites W2006796442 @default.
• W2898294136 cites W2023765040 @default.
• W2898294136 cites W2024318945 @default.
• W2898294136 cites W2046130605 @default.
• W2898294136 cites W2086430491 @default.
• W2898294136 cites W2146993009 @default.
• W2898294136 cites W2151853926 @default.
• W2898294136 cites W2160936126 @default.
• W2898294136 cites W2474594246 @default.
• W2898294136 cites W2546807589 @default.
• W2898294136 cites W2564728522 @default.
• W2898294136 cites W2566662160 @default.
• W2898294136 cites W2608673350 @default.
• W2898294136 cites W2613226078 @default.
• W2898294136 cites W2768587756 @default.
• W2898294136 cites W2778036983 @default.
• W2898294136 cites W2790015545 @default.
• W2898294136 cites W4233170993 @default.
• W2898294136 doi "https://doi.org/10.1089/mab.2018.0035" @default.
• W2898294136 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6208159" @default.
• W2898294136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30362926" @default.
• W2898294136 hasPublicationYear "2018" @default.
• W2898294136 type Work @default.
• W2898294136 sameAs 2898294136 @default.
• W2898294136 citedByCount "10" @default.
• W2898294136 countsByYear W28982941362019 @default.
• W2898294136 countsByYear W28982941362020 @default.
• W2898294136 countsByYear W28982941362022 @default.
• W2898294136 crossrefType "journal-article" @default.
• W2898294136 hasAuthorship W2898294136A5000775867 @default.
• W2898294136 hasAuthorship W2898294136A5016361449 @default.
• W2898294136 hasAuthorship W2898294136A5016375050 @default.
• W2898294136 hasAuthorship W2898294136A5025832428 @default.
• W2898294136 hasAuthorship W2898294136A5032655219 @default.
• W2898294136 hasAuthorship W2898294136A5050043235 @default.
• W2898294136 hasAuthorship W2898294136A5060363731 @default.
• W2898294136 hasAuthorship W2898294136A5077624041 @default.
• W2898294136 hasBestOaLocation W28982941361 @default.
• W2898294136 hasConcept C153911025 @default.
• W2898294136 hasConcept C159654299 @default.
• W2898294136 hasConcept C165901193 @default.
• W2898294136 hasConcept C170493617 @default.
• W2898294136 hasConcept C175656101 @default.
• W2898294136 hasConcept C181152851 @default.
• W2898294136 hasConcept C185592680 @default.
• W2898294136 hasConcept C203014093 @default.
• W2898294136 hasConcept C2775848585 @default.
• W2898294136 hasConcept C2777629521 @default.
• W2898294136 hasConcept C2909316934 @default.
• W2898294136 hasConcept C40677261 @default.
• W2898294136 hasConcept C542903549 @default.
• W2898294136 hasConcept C552990157 @default.
• W2898294136 hasConcept C553184892 @default.
• W2898294136 hasConcept C55493867 @default.
• W2898294136 hasConcept C81089528 @default.
• W2898294136 hasConcept C86803240 @default.
• W2898294136 hasConceptScore W2898294136C153911025 @default.
• W2898294136 hasConceptScore W2898294136C159654299 @default.
• W2898294136 hasConceptScore W2898294136C165901193 @default.
• W2898294136 hasConceptScore W2898294136C170493617 @default.
• W2898294136 hasConceptScore W2898294136C175656101 @default.
• W2898294136 hasConceptScore W2898294136C181152851 @default.
• W2898294136 hasConceptScore W2898294136C185592680 @default.
• W2898294136 hasConceptScore W2898294136C203014093 @default.
• W2898294136 hasConceptScore W2898294136C2775848585 @default.
• W2898294136 hasConceptScore W2898294136C2777629521 @default.
• W2898294136 hasConceptScore W2898294136C2909316934 @default.
• W2898294136 hasConceptScore W2898294136C40677261 @default.
• W2898294136 hasConceptScore W2898294136C542903549 @default.
• W2898294136 hasConceptScore W2898294136C552990157 @default.
• W2898294136 hasConceptScore W2898294136C553184892 @default.
• W2898294136 hasConceptScore W2898294136C55493867 @default.
• W2898294136 hasConceptScore W2898294136C81089528 @default.
• W2898294136 hasConceptScore W2898294136C86803240 @default.
• W2898294136 hasIssue "5" @default.
• W2898294136 hasLocation W28982941361 @default.
• W2898294136 hasLocation W28982941362 @default.
• W2898294136 hasLocation W28982941363 @default.
• W2898294136 hasLocation W28982941364 @default.
• W2898294136 hasOpenAccess W2898294136 @default.

• next